天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

返回ChemicalBook首頁(yè)>CAS數(shù)據(jù)庫(kù)列表>2059952-75-7

2059952-75-7

中文名稱 STAT3-IN-1
英文名稱 STAT3-IN-1
CAS 2059952-75-7
分子式 C28H29NO6
分子量 475.53
MOL 文件 2059952-75-7.mol
更新日期 2024/12/23 09:08:09
2059952-75-7 結(jié)構(gòu)式 2059952-75-7 結(jié)構(gòu)式

基本信息

中文別名
化合物STAT3-IN-1
英文別名
STAT3-IN-1
2-Propenamide, N-[4-[(1E)-2-(3,5-dimethoxyphenyl)ethenyl]phenyl]-3-(3,4,5-trimethoxyphenyl)-, (2E)-

物理化學(xué)性質(zhì)

沸點(diǎn)689.3±55.0 °C(Predicted)
密度1.205±0.06 g/cm3(Predicted)
儲(chǔ)存條件Sealed in dry,Room Temperature
溶解度DMSO: 125 mg/mL (262.86 mM)
酸度系數(shù)(pKa)12.63±0.70(Predicted)
形態(tài)Solid
顏色Light yellow to orange

安全數(shù)據(jù)

危險(xiǎn)性符號(hào)(GHS)GHS hazard pictograms
GHS07
警示詞警告
危險(xiǎn)性描述H302-H315-H319-H335
防范說(shuō)明P261-P305+P351+P338

常見(jiàn)問(wèn)題列表

生物活性
STAT3-IN-1 (compound 7d) 是一種出色的、選擇性的 STAT3 的口服活性抑制劑,在HT29細(xì)胞和MDA-MB 231細(xì)胞中的IC50值分別為1.82 μM和2.14 μM。STAT3-IN-1 誘導(dǎo)腫瘤細(xì)胞凋亡。
靶點(diǎn)
TargetValue
STAT3
(in HT29 cells)
1.82 μM
STAT3
(in MDA-MB 231 cells)
2.14 μM
體外研究

STAT3-IN-1 (compound 7d: 0-10 μM, 48 h) inhibits the STAT3 acetylation at lysine 685 and affected its specific genes expressions.
STAT3-IN-1 (compound 7d: 0-10 μM, 48 h) induces tumor cells apoptosis in MDA-MB-231 cells.

Apoptosis Analysis

Cell Line: MDA-MB-231 cell lines.
Concentration: 0-10 μM.
Incubation Time: 48 hours.
Result: The induced apoptosis rates (early and late apoptosis) at 1, 2, 5, 8 and 10 μM were 9.0%, 11.2%, 20.9%, 43.3% and 85.2% versus control 3.0%.

Western Blot Analysis

Cell Line: MDA-MB-231 and HT-29 cell lines.
Concentration: 0-10 μM.
Incubation Time: 48 hours.
Result: Inhibited STAT3 acetylation and STAT3 tyrosine phosphorylation in MDA-MB-231 cells.
Increased the expressions of these tumor-suppressor genes (PTPN6 (SHP-1), CDKN2A and DLEC1) which were related to STAT3 acetylation at Lys685.
體內(nèi)研究

STAT3-IN-1 (compound 7d: 10, 20 mg/kg, two weeks) arrests tumor growth with low toxicity in mouse-xenograft model.

Animal Model: Mouse-xenograft model bearing inoculation of mice breast cancer 4T1 cells.
Dosage: 10, 20 mg/kg.
Administration: Oral administration once every other day for two weeks.
Result: Arrested tumor growth with no obvious body weight loss.
"2059952-75-7" 相關(guān)產(chǎn)品信息